Published in Cancer Biol Ther on May 05, 2010
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients. Cancer Biol Ther (2013) 1.26
Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2. Bioorg Med Chem Lett (2012) 0.82
A perspective on the role of class III semaphorin signaling in central nervous system trauma. Front Cell Neurosci (2014) 0.80
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet (2010) 2.24
Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis (2007) 2.21
The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Clin Endocrinol (Oxf) (2007) 1.73
Oxidative stress effects on endothelial cells treated with different athletes' sera. Med Sci Sports Exerc (2012) 1.62
Accelerated epigenetic aging in Down syndrome. Aging Cell (2015) 1.61
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab (2007) 1.53
'Here comes the sun': pigmentary traits and sun habits in women with endometriosis. Hum Reprod (2010) 1.48
Gynaecomastia in men with chronic myeloid leukaemia after imatinib. Lancet (2003) 1.47
Methylation of ELOVL2 gene as a new epigenetic marker of age. Aging Cell (2012) 1.45
Role of GPR30 in testicular germ cell tumors: a potential new anticancer target. Cancer Biol Ther (2011) 1.43
Role of epigenetics in human aging and longevity: genome-wide DNA methylation profile in centenarians and centenarians' offspring. Age (Dordr) (2012) 1.33
Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease? Gut (2011) 1.31
Acromegaly. Pituitary (2006) 1.26
Isolated corticotrophin deficiency. Pituitary (2006) 1.11
Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J Clin Endocrinol Metab (2002) 1.11
Caution during use of desmopressin in IPSS. J Neurointerv Surg (2012) 1.07
PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy. Endocrine (2014) 1.06
Hypopituitarism. Pituitary (2006) 1.06
Gender-related differences in the presentation and course of Cushing's disease. J Clin Endocrinol Metab (2003) 1.03
Low circulating IGF-I bioactivity is associated with human longevity: findings in centenarians' offspring. Aging (Albany NY) (2012) 1.01
Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series. J Clin Endocrinol Metab (2007) 0.99
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. Biotechnol Adv (2011) 0.98
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet (2013) 0.98
Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome. J Clin Endocrinol Metab (2003) 0.98
An Italian association study and meta-analysis with previous GWAS confirm WNT4, CDKN2BAS and FN1 as the first identified susceptibility loci for endometriosis. J Med Genet (2012) 0.96
Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab (2010) 0.95
Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa. Front Neuroendocrinol (2003) 0.93
Growth hormone deficiency (GHD) in adult thalassaemic patients. Clin Endocrinol (Oxf) (2007) 0.92
Potential role for retinoic acid in patients with Cushing's disease. J Clin Endocrinol Metab (2012) 0.92
Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients. Clin Endocrinol (Oxf) (2006) 0.90
Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure. Clin Endocrinol (Oxf) (2012) 0.89
Elastosonographic evaluation of thyroid nodules in acromegaly. Eur J Endocrinol (2009) 0.89
ACTH-secreting pheochromocytoma with false-negative ACTH immunohistochemistry. Endocr Pathol (2012) 0.88
The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation. Hum Reprod (2012) 0.87
Differences in visceral fat and fat bacterial colonization between ulcerative colitis and Crohn's disease. An in vivo and in vitro study. PLoS One (2013) 0.87
Assessment of ACTH assay variability: a multicenter study. Eur J Endocrinol (2011) 0.87
Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy. Circ Cardiovasc Genet (2017) 0.87
Deregulated human glioma cell motility: inhibitory effect of somatostatin. Mol Cell Endocrinol (2006) 0.86
Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease. Clin Endocrinol (Oxf) (2006) 0.86
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial. Cancer Biol Ther (2010) 0.86
Von Willebrand factor and fibrinolytic parameters during the desmopressin test in patients with Cushing's disease. Br J Clin Pharmacol (2011) 0.85
Type I interferons: ancient peptides with still under-discovered anti-cancer properties. Protein Pept Lett (2013) 0.85
Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma. J Clin Endocrinol Metab (2009) 0.85
Meningioma presenting with Cushing's syndrome: an unusual clinical presentation. Ann Neurol (2003) 0.84
High prevalence of prolonged QT interval in obese hypogonadal males. Obesity (Silver Spring) (2011) 0.83
Drugs and HPA axis. Pituitary (2008) 0.83
Characterisation and cytomodulatory properties of peptides from Mozzarella di Bufala Campana cheese whey. J Pept Sci (2009) 0.83
Molecular and morphologic characterization of superficial- and deep-subcutaneous adipose tissue subdivisions in human obesity. Obesity (Silver Spring) (2013) 0.82
Zebrafish as an innovative model for neuroendocrine tumors. Endocr Relat Cancer (2014) 0.82
The diagnosis of GH deficiency in obese patients: a reappraisal with GHRH plus arginine testing after pharmacological blockade of lipolysis. Eur J Endocrinol (2010) 0.82
Cushing's disease. Pituitary (2006) 0.81
A novel quinone-based derivative (DTNQ-Pro) induces apoptotic death via modulation of heat shock protein expression in Caco-2 cells. Br J Pharmacol (2010) 0.81
The pituitary-adrenal axis in adult thalassaemic patients. Eur J Endocrinol (2009) 0.81
Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report. Endocr J (2010) 0.81
Bone demineralization in adult thalassaemic patients: contribution of GH and IGF-I at different skeletal sites. Clin Endocrinol (Oxf) (2008) 0.80
Gender-dependent changes in haematological parameters in patients with Cushing's disease before and after remission. Eur J Endocrinol (2014) 0.79
Pericardial effusion requiring pericardiocentesis in a girl with anorexia nervosa. Int J Eat Disord (2006) 0.79
Peptides from water buffalo cheese whey induced senescence cell death via ceramide secretion in human colon adenocarcinoma cell line. Mol Nutr Food Res (2010) 0.78
Carney's complex with acromegaly as the leading clinical condition. Clin Endocrinol (Oxf) (2007) 0.78
Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies. J Clin Endocrinol Metab (2013) 0.78
Interferon-inducible genes, TNF-related apoptosis-inducing ligand (TRAIL) and interferon inducible protein 27 (IFI27) are negatively regulated in leiomyomas: implications for a role of the interferon pathway in leiomyoma development. Gynecol Endocrinol (2012) 0.78
DTNQ-Pro, a Mimetic Dipeptide, Sensitizes Human Colon Cancer Cells to 5-Fluorouracil Treatment. J Amino Acids (2013) 0.78
Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity. Eur J Endocrinol (2003) 0.78
Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease. Eur J Endocrinol (2007) 0.77
Interplay between membrane lipid peroxidation, transglutaminase activity, and cyclooxygenase 2 expression in the tissue adjoining to breast cancer. J Cell Physiol (2012) 0.77
A new therapeutic strategy against cancer: cAMP elevating drugs and leptin. Cancer Biol Ther (2009) 0.77
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines. Endocrine (2015) 0.77
Gamma-glutamyl 16-diaminopropane derivative of vasoactive intestinal peptide: a potent anti-oxidative agent for human epidermoid cancer cells. Amino Acids (2010) 0.77
Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy. Clin Endocrinol (Oxf) (2012) 0.77
Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease. Clin Exp Pharmacol Physiol (2013) 0.77
Nutritional management of anorexic patients with and without fluoxetine: 1-year follow-up. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.77
The endocannabinoid pathway and the female reproductive organs. J Mol Endocrinol (2013) 0.77
Effects of VIP and VIP-DAP on proliferation and lipid peroxidation metabolism in human KB cells. Ann N Y Acad Sci (2006) 0.76
AZA-deoxycytidine stimulates proopiomelanocortin gene expression and ACTH secretion in human pituitary ACTH-secreting tumors. Pituitary (2014) 0.76
In vitro stimulatory effect of anti-apoptotic seminal vesicle protein 4 on purified peroxidase enzymes. FEBS J (2008) 0.76
Pyk2 and Cyr61 at the cross-road of cAMP-dependent signalling in invasiveness and neuroendocrine differentiation of prostate cancer. Cancer Biol Ther (2009) 0.76
Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy. Recent Pat Anticancer Drug Discov (2016) 0.76
Antiphospholipid Antibodies and Infertility: A Gene Expression Study in Decidual Stromal Cells. Isr Med Assoc J (2016) 0.76
Low insulin-like growth factor I and leukopenia in anorexia nervosa. Int J Eat Disord (2008) 0.75
Potential role of type I interferons in the treatment of pituitary adenomas. Rev Endocr Metab Disord (2008) 0.75
Differential diagnosis of ACTH-dependent hypercortisolism: imaging versus laboratory. Pituitary (2009) 0.75
Seminal vesicle protein IV and its derived active peptides: a possible physiological role in seminal clotting. Semin Thromb Hemost (2007) 0.75
Cushing's disease and pregnancy. Pituitary (2004) 0.75
Advances in the medical management of Cushing's syndrome. Expert Opin Pharmacother (2008) 0.75
A rare familial case of endometriosis with very severe gynecological and obstetric complications: novel genetic variants at a glance. Gynecol Obstet Invest (2014) 0.75
Assessment of the conformational features of vasoactive intestinal peptide in solution by limited proteolysis experiments. Biopolymers (2006) 0.75